Cargando…

Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey

BACKGROUND: Pseudohypoparathyroidism (PHP) and nonsurgical hypoparathyroidism (NS-HypoPT) are rare diseases with hypocalcemia, hyperphosphatemia, and high and low parathyroid hormone levels, respectively. In Japan, over 20 years have passed since the last survey on these diseases. We carried out a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Takatani, Rieko, Kubota, Takuo, Minagawa, Masanori, Inoue, Daisuke, Fukumoto, Seiji, Ozono, Keiichi, Nakamura, Yosikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518380/
https://www.ncbi.nlm.nih.gov/pubmed/36123043
http://dx.doi.org/10.2188/jea.JE20220152
_version_ 1785109500417540096
author Takatani, Rieko
Kubota, Takuo
Minagawa, Masanori
Inoue, Daisuke
Fukumoto, Seiji
Ozono, Keiichi
Nakamura, Yosikazu
author_facet Takatani, Rieko
Kubota, Takuo
Minagawa, Masanori
Inoue, Daisuke
Fukumoto, Seiji
Ozono, Keiichi
Nakamura, Yosikazu
author_sort Takatani, Rieko
collection PubMed
description BACKGROUND: Pseudohypoparathyroidism (PHP) and nonsurgical hypoparathyroidism (NS-HypoPT) are rare diseases with hypocalcemia, hyperphosphatemia, and high and low parathyroid hormone levels, respectively. In Japan, over 20 years have passed since the last survey on these diseases. We carried out a nationwide cross-sectional survey to estimate the prevalence of these diseases in 2018. METHODS: We conducted a nationwide mail-based survey targeting hospitals in 2018. From a total of 13,156 departments throughout Japan, including internal medicine, pediatrics, neurology, and psychiatry, 3,501 (27%) departments were selected using a stratified random sampling method. We asked each included department to report the number of patients with PHP and NS-HypoPT in 2017. RESULTS: The overall survey response rate was 52.0% (1,807 departments). The estimated number of patients with PHP and NS-HypoPT was 1,484 (95% confidence interval [CI], 1,143–1,825) and 2,304 (95% CI, 1,189–3,419), respectively; the prevalence per 100,000 population was 1.2 and 1.8, respectively. CONCLUSION: In this study, we generated estimates of the national prevalence of PHP and NS-HypoPT in Japan during 2017, which were found to be higher than those previously reported.
format Online
Article
Text
id pubmed-10518380
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Epidemiological Association
record_format MEDLINE/PubMed
spelling pubmed-105183802023-11-05 Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey Takatani, Rieko Kubota, Takuo Minagawa, Masanori Inoue, Daisuke Fukumoto, Seiji Ozono, Keiichi Nakamura, Yosikazu J Epidemiol Original Article BACKGROUND: Pseudohypoparathyroidism (PHP) and nonsurgical hypoparathyroidism (NS-HypoPT) are rare diseases with hypocalcemia, hyperphosphatemia, and high and low parathyroid hormone levels, respectively. In Japan, over 20 years have passed since the last survey on these diseases. We carried out a nationwide cross-sectional survey to estimate the prevalence of these diseases in 2018. METHODS: We conducted a nationwide mail-based survey targeting hospitals in 2018. From a total of 13,156 departments throughout Japan, including internal medicine, pediatrics, neurology, and psychiatry, 3,501 (27%) departments were selected using a stratified random sampling method. We asked each included department to report the number of patients with PHP and NS-HypoPT in 2017. RESULTS: The overall survey response rate was 52.0% (1,807 departments). The estimated number of patients with PHP and NS-HypoPT was 1,484 (95% confidence interval [CI], 1,143–1,825) and 2,304 (95% CI, 1,189–3,419), respectively; the prevalence per 100,000 population was 1.2 and 1.8, respectively. CONCLUSION: In this study, we generated estimates of the national prevalence of PHP and NS-HypoPT in Japan during 2017, which were found to be higher than those previously reported. Japan Epidemiological Association 2023-11-05 /pmc/articles/PMC10518380/ /pubmed/36123043 http://dx.doi.org/10.2188/jea.JE20220152 Text en © 2022 Rieko Takatani et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Takatani, Rieko
Kubota, Takuo
Minagawa, Masanori
Inoue, Daisuke
Fukumoto, Seiji
Ozono, Keiichi
Nakamura, Yosikazu
Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title_full Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title_fullStr Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title_full_unstemmed Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title_short Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey
title_sort prevalence of pseudohypoparathyroidism and nonsurgical hypoparathyroidism in japan in 2017: a nationwide survey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518380/
https://www.ncbi.nlm.nih.gov/pubmed/36123043
http://dx.doi.org/10.2188/jea.JE20220152
work_keys_str_mv AT takatanirieko prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT kubotatakuo prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT minagawamasanori prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT inouedaisuke prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT fukumotoseiji prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT ozonokeiichi prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey
AT nakamurayosikazu prevalenceofpseudohypoparathyroidismandnonsurgicalhypoparathyroidisminjapanin2017anationwidesurvey